Kim SH, Jung E, Yoon MK, Kwon OH, Hwang DM, Kim DW, Kim J, Lee SM, Yim HJ (2016) <br />Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo<br /><i>European Journal of Pharmacology</i> <b>788</b>: 54<br /><br />Lim KS, Kim JR, Choi YJ, Shin KH, Kim KP, Hong JH, Cho JY, Shin HS, Yu KS, Shin SG, Kwon OH, Hwang DM, Kim JA, Jang IJ (2008) <br />Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study<br /><i>Clin Ther</i> <b>30</b>: 1817<br /><br />Koo KD, Kim MJ, Kim S, Kim KH, Hong SY, Hur GC, Yim HJ, Kim GT, Han HO, Kwon OH, Kwon TS, Koh JS, Lee CS (2007) <br />Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors: oxadiazolyl ketones<br /><i>Bioorganic & Medicinal Chemistry Lett</i> <b>17</b>: 4167<br /><br />